Department of Defense explores AI-enabled infection control

The technology examines vital signs and other biomarkers to predict the likelihood of infection


The technology, developed in part by the U.S. Department of Defense (DoD), examines vital signs and other biomarkers to predict the likelihood of infection up to 48 hours ahead of clinical suspicion, according to an article on the Healthcare IT News website.

The technology is intended for U.S. service members but expected to be used widely by civilians. 

The healthcare technology company, Royal Philips, and the DoD collaborated on the 18-month project.

The technology is expected to be broadly applicable to civilian healthcare settings. It will eventually be used in scenarios where vital signs and biomarkers fluctuate, like during physical exertion and heat stress.

Read the article.



October 29, 2019


Topic Area: Infection Control

Recent Posts

Retrofitting Healthcare Facilities for EV Charging

With EV adoption growing, healthcare facilities may face some challenges when retrofitting their buildings for charging.

Healthcare Real Estate: Challenges and Industry Shifts for 2025

The hurdles include balancing expansion with financial constraints, the sustainability of office and retail conversions, and technological disruptions.

Geisinger to Build $32 Million Cancer Center in Pennsylvania

The two-story, 40,000-square-foot facility will be home to the cancer center with space for future growth of services.

Sunflower Medical Group Experiences Data Breach

To date, Sunflower has no evidence that personal information has been misused.

Strategies to Eradicate Biofilm Containing C. Auris

Understanding the speed and risks of contamination after room disinfection should inform managers’ environmental cleaning recommendations.

 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.